Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase EARLY_PHASE1 2Phase 2 1Phase 1 1

Status

Recruiting 3Suspended 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 6INDUSTRY 3

Study Type

Interventional 6

Sponsor

Cancer Type

Gastrointestinal 6

Conditions

Breast Neoplasms 930Neoplasms 708Prostatic Neoplasms 490Lung Neoplasms 398Carcinoma, Non-Small-Cell Lung 359Colorectal Neoplasms 357Leukemia, Myeloid, Acute 290Pancreatic Neoplasms 238Brain Neoplasms 227Neoplasm Metastasis 221Multiple Myeloma 214Carcinoma, Hepatocellular 199Head and Neck Neoplasms 182Glioblastoma 181Precursor Cell Lymphoblastic Leukemia-Lymphoma 177Melanoma 173Ovarian Neoplasms 168Squamous Cell Carcinoma of Head and Neck 160Uterine Cervical Neoplasms 144Rectal Neoplasms 144Recurrence 142Hematologic Neoplasms 134Sarcoma 133Triple Negative Breast Neoplasms 127Stomach Neoplasms 127Glioma 126Carcinoma, Renal Cell 123Colonic Neoplasms 113Myelodysplastic Syndromes 112Urinary Bladder Neoplasms 109

Interventions

paricalcitol 1mitazalimab 1Specimen Handling 1Positron Emission Tomography Computed Tomography 1Parturition 1Neoadjuvant Therapy 1Losartan 1Hydroxychloroquine 1Glucose 1Fecal Microbiota Transplantation 1Contrast Media 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
OTHER × Pancreatic Ductal Adenocarcinoma × 90 days × Clear all
NCT04975217 2026-05-22

Fecal Microbial Transplants for the Treatment of Pancreatic Cancer

M.D. Anderson Cancer Center

Phase EARLY_PHASE1 Suspended
10 enrolled
Gastrointestinal

Pancreatic Ductal Adenocarcinoma

NCT05365893 2026-05-22

PHL Treatment in Pancreatic Cancer

Fox Chase Cancer Center

Phase EARLY_PHASE1 Active not recruiting
20 enrolled
Gastrointestinal

Pancreatic Ductal Adenocarcinoma

NCT03851237 2026-05-08

CCR2 PET for Pancreatic Cancer Imaging and Prediction of Response to Standard and CCR2-Targeted Therapy

Washington University School of Medicine

Phase 1 Completed
69 enrolled
Gastrointestinal

Pancreatic Ductal Adenocarcinoma

NCT05296421 2026-05-04

Investigating Targetable Metabolic Pathways Sustaining Pancreatic Cancer

Rutgers, The State University of New Jersey

Phase NA Recruiting
16 enrolled
Gastrointestinal

Pancreatic Ductal Adenocarcinoma

NCT07324096 2026-03-27

AI-PACED

Mayo Clinic

Phase NA Recruiting
100 enrolled
Gastrointestinal

Pancreatic Ductal Adenocarcinoma

NCT07199764 2026-03-06

IGNITE

University of Pennsylvania

Phase 2 Recruiting
100 enrolled
Gastrointestinal

Pancreatic Ductal Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡